Logo

Natco Pharma Share Price

Natco Pharma (INR)1235.55-52.8   (-4.1%)

Exchange ScripsBSE524816NSENATCOPHARMISININE987B01026

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Natco Pharma Performance

Market performance
Open price1293.2
High1294.4
Volumes587204
Prev Close1235.55
Low1230
Closing date2025-01-10
Historical performance
1 Year High1639.00
3 Year High1639.00
5 Year High1639.00
1 Year Low805.00
3 Year Low502.00
5 Year Low402.55

Natco Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
22118
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
15.93
Dividend Yield
Dividend Yield
0.38 %

Natco Pharma Investment Returns

1 Year
47%
3 Years
34.9%
5 Years
100%
10 Years
337.6%

Natco Pharma Technicals

IndicatorsValueSignal
5-DMA1295.52Bearish
10-DMA1341.25Bearish
20-DMA1378.5Bearish
50-DMA1394.87Bearish
100-DMA1428.43Bearish
200-DMA1278.86Bearish

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters2121212121
Foreign Investors---------------
Domestic Investors2121212121
Public Investors345311302923251464228446207550
Government------1------

Natco Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income128112859901060
Operating Profit187951040236257098
Interest192145177133
Depreciation1868163814261169
Profit Before Tax16735861920225796
Consolidated Net Profit13883715317004409
Adjusted EPS7839924

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital358365365365
Total Reserves58173483734223740676
Minority Interest---------18
Total Non-Current Liabilities610100513511429
Total Liabilities68869565745109147919
Capital Work in Progress137364312952234
Total Assets68869565745109147919

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities1211684914652988
Cash Flow from Investing Activities-10327-4771-53-1033
Cash Flow from Financing Activitie-2469-3630348-1857
Net Cash Inflow / Outflow-6809076098
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 15.93.
  • 3Y Stock Price CAGR of the stock is 10.3.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹18795 Million.
  • The company generated revenue of ₹39988 Million in the previous financial year.

Natco Pharma

1235.55-52.8   (-4.1%)

Investment Amount: ₹ 84850
Current Value: ₹ 123555
Performance: 45.6%
P/L: ₹ 38705
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
AWL291.1(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month